142 related articles for article (PubMed ID: 33368804)
1. NXP2-positive dermatomyositis complicated with refractory skin edema: Successful treatment with tocilizumab.
Lu Z; Chen Y; Xue J; Liu L
Dermatol Ther; 2021 Jan; 34(1):e14712. PubMed ID: 33368804
[No Abstract] [Full Text] [Related]
2. Juvenile dermatomyositis presenting with periorbital edema.
Taban M; Perry JD
Ophthalmic Plast Reconstr Surg; 2006; 22(5):393-5. PubMed ID: 16985429
[TBL] [Abstract][Full Text] [Related]
3. Periorbital edema as the presenting sign of dermatomyositis.
Hall VC; Keeling JH; Davis MD
Int J Dermatol; 2003 Jun; 42(6):466-7. PubMed ID: 12786876
[TBL] [Abstract][Full Text] [Related]
4. Dermatomyositis presenting with severe subcutaneous edema: five additional cases and review of the literature.
Milisenda JC; Doti PI; Prieto-González S; Grau JM
Semin Arthritis Rheum; 2014 Oct; 44(2):228-33. PubMed ID: 24830790
[TBL] [Abstract][Full Text] [Related]
5. Anti-NXP2 Positive Dermatomyositis Causing Rhabdomyolysis: An Atypical Presentation.
Shah V; Yaffe B; Gutman D
Am J Med Sci; 2022 May; 363(5):e49-e50. PubMed ID: 34986363
[No Abstract] [Full Text] [Related]
6. A case of overlap syndrome successfully treated with tocilizumab: a hopeful treatment strategy for refractory dermatomyositis?
Kondo M; Murakawa Y; Matsumura T; Matsumoto O; Taira M; Moriyama M; Sumita Y; Yamaguchi S
Rheumatology (Oxford); 2014 Oct; 53(10):1907-8. PubMed ID: 24859996
[No Abstract] [Full Text] [Related]
7. Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib.
Navarro-Navarro I; Jiménez-Gallo D; Rodríguez-Mateos ME; Rodríguez-Hernández C; Linares-Barrios M
J Dtsch Dermatol Ges; 2021 Mar; 19(3):443-447. PubMed ID: 32909360
[No Abstract] [Full Text] [Related]
8. Juvenile dermatomyositis presenting with anasarca.
Saygi S; Alehan F; Baskin E; Bayrakci US; Ulu EM; Ozbek N
J Child Neurol; 2008 Nov; 23(11):1353-6. PubMed ID: 18984850
[TBL] [Abstract][Full Text] [Related]
9. Periorbital Edema as the Initial Sign of Juvenile Dermatomyositis.
Shimizu M; Inoue N; Mizuta M; Sakakibara Y; Hamaguchi Y; Yachie A
J Clin Rheumatol; 2020 Apr; 26(3):e61. PubMed ID: 30234551
[No Abstract] [Full Text] [Related]
10. Dermatomyositis associated with generalized subcutaneous edema and Evans syndrome.
Jung KD; Kim PS; Park HY; Kim CR; Byun JY; Lee DY; Lee JH; Yang JM; Lee ES
J Am Acad Dermatol; 2012 Jan; 66(1):144-7. PubMed ID: 22030016
[TBL] [Abstract][Full Text] [Related]
11. Unilateral Eyelid Swelling as a Sign of Antimelanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Antibody-Positive Dermatomyositis.
Lam SC; Yuen HKL
Ophthalmic Plast Reconstr Surg; 2018; 34(6):e209-e211. PubMed ID: 30365479
[TBL] [Abstract][Full Text] [Related]
12. Periorbital and facial swelling due to dermatomyositis.
Rafailidis PI; Kapaskelis A; Falagas ME
CMAJ; 2007 May; 176(11):1580-1. PubMed ID: 17515583
[No Abstract] [Full Text] [Related]
13. Eyelid edema as first manifestation of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease: A case report.
Ludriksone L; Pfeil A; Schliemann S; Elsner P
J Dtsch Dermatol Ges; 2020 Mar; 18(3):263-265. PubMed ID: 31922645
[No Abstract] [Full Text] [Related]
14. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
[TBL] [Abstract][Full Text] [Related]
15. Limb edema and anasarca associated with severe dermatomyositis: report of four cases.
Chai Y; Bertorini TE; Li YD; Mitchell C; Guan H
Neuromuscul Disord; 2011 Jun; 21(6):439-42. PubMed ID: 21482469
[TBL] [Abstract][Full Text] [Related]
16. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
17. Edema and dermatomyositis. Migratory edema and edematous and vesiculobullous dermatomyositis overlap.
Lozano-Masdemont B; Pulido-Pérez A; Parra-Blanco V; Avilés-Izquierdo JA
Reumatol Clin (Engl Ed); 2018; 14(5):313-314. PubMed ID: 29107577
[No Abstract] [Full Text] [Related]
18. Contribution of the Interferon score in the management of an anti-NXP2 dermatomyositis patient with calcinosis successfully treated with tofacitinib.
Robert M; Gallay L; Garnier L; Pescarmona R; Hot A
Joint Bone Spine; 2023 Jul; 90(4):105532. PubMed ID: 36706944
[No Abstract] [Full Text] [Related]
19. [Juvenile dermatomyositis presenting with anasarca: a possible new variant].
Lúcio Filho CE; Carvalho LI; Carvalho LL; Almeida Mdo S; Budaruiche JS
Acta Reumatol Port; 2008; 33(2):238-42. PubMed ID: 18604189
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous oedema of upper limbs heralding an aggressive form of dermatomyositis.
Shukla M; Patel R; Kuzyshyn H; Feinstein D
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29848519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
